All of these preparations are manufactured by the Danish pharmaceutical company Novo Nordisk, but they differ regarding approved indication and how they are administered
Notably, this comes as the FDA introduced a so-called Green List in September 2025: a mechanism aimed at preventing potentially unsafe active pharmaceutical ingredients (APIs) from unverified foreign sources, particularly those for GLP-1 drugs, from entering the U.S
It's important to note that Ozempic (semaglutide) is licensed specifically for type 2 diabetes treatment, while Wegovy (also semaglutide but at different doses) is licensed for weight management
I think growing up, he just didn't understand why I couldn't lose weight and why I looked different than my family, said Hamilton, as she sipped hot tea on the back patio of her favorite coffee shop in Arvada
This could be attributed to its dual GLP-1 and GIP receptor agonist mechanism, which enhances metabolic regulation
retatrutides analogous long-term safety envelope has not been established
